TP53 inactivation, prevalent in MEITL and rare in EATL, likely cooperates with SETD2 alterations to exacerbate genomic instability and override DNA damage checkpoints. The gene discussed is SETD2; the disease is enteropathy-associated T-cell lymphoma.